mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.006 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.007 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.007 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.008 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.009 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.009 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
0.32 |
0.009 |